Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3153473 | 0.93 | — | — | |
| SCHEMBL652869 | 0.90 | — | — | |
| SCHEMBL22339943 | 0.90 | — | — | |
| Succinic Acid SCHEMBL28878150 | 0.84 | CYP1A2 (0.43) | CYP1A2FOLH1 | |
| SCHEMBL2388469 | 0.77 | — | — | |
| SCHEMBL2387753 | 0.77 | — | — | |
| Tetrahydrofuran SCHEMBL28137719 | 0.74 | ALDH1A1 (0.34) | — | |
| SCHEMBL10412398 | 0.74 | ALDH1A1 (0.35) | TP53 | |
| SCHEMBL9416705 | 0.73 | — | — | |
| SCHEMBL3053013 | 0.73 | GABRR1 (0.41) | GABRR1CYP1A2FOLH1NAALAD2ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110196170-A1 | METHOD FOR PRODUCING ASTAXANTHIN DIMETHYLDISUCCINATE | BASF SE (DE) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110196170-A1 | METHOD FOR PRODUCING ASTAXANTHIN DIMETHYLDISUCCINATE | ALAD, FDFT1, AMD1 | GABRR1 4111/4885CYP1A2 794/4885FOLH1 1822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.